Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

395 ARTÍCULOS , VIENDO DEL 286 AL 300

Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review

Chaudhry A, Houlden H, Rizig M.

J Neurol Sci. 2020 Aug 15;415:116886. doi: 10.1016/j.jns.2020.116886. Epub 2020 May 11.

Early Detection of Mild Cognitive Impairment (MCI) in Primary Care

Sabbagh MN, Boada M, Borson S, Chilukuri M, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):165-170. doi: 10.14283/jpad.2020.21.

Buccal Mucosa Biomarkers in Alzheimer's Disease

Avramouli A, Vlamos P.

Adv Exp Med Biol. 2020;1195:49-56. doi: 10.1007/978-3-030-32633-3_8.

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease

Khan S, Barve KH, Kumar MS.

Curr Neuropharmacol. 2020;18(11):1106-1125. doi: 10.2174/1570159X18666200528142429.

Exploring the Potential of Neuroproteomics in Alzheimer's Disease

Uddin MS, Kabir MT, Jakaria M, Sobarzo-Sánchez E, Barreto GE, Perveen A, Hafeez A, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

Curr Top Med Chem. 2020;20(25):2263-2278. doi: 10.2174/1568026620666200603112030.

Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers

Mobed A, Hasanzadeh M.

Int J Biol Macromol. 2020 Oct 15;161:59-71. doi: 10.1016/j.ijbiomac.2020.05.257. Epub 2020 Jun 3.

Advent of Proteomic Tools for Diagnostic Biomarker Analysis in Alzheimer's Disease

Singh M, Singh SP, Dubey PK, Rachana R, Mani S, Yadav D, Agarwal M, Agarwal S, Agarwal V, Kaur H.

Curr Protein Pept Sci. 2020;21(10):965-977. doi: 10.2174/1389203721666200615173213.

Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions

Bermejo-Pareja F, Del Ser T, Valentí M, de la Fuente M, Bartolome F, Carro E.

Alzheimers Dement. 2020 Aug;16(8):1196-1204. doi: 10.1002/alz.12107. Epub 2020 Jun 16.

Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks

Guthrie H, Honig LS, Lin H, Sink KM, Blondeau K, Quartino A, Dolton M, Carrasco-Triguero M, Lian Q, Bittner T, Clayton D, Smith J, Ostrowitzki S.

J Alzheimers Dis. 2020;76(3):967-979. doi: 10.3233/JAD-200134.

Towards a Redefinition of Cognitive Frailty

Mantovani E, Zucchella C, Schena F, Romanelli MG, Venturelli M, Tamburin S.

J Alzheimers Dis. 2020;76(3):831-843. doi: 10.3233/JAD-200137.

Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers

Kim K , Lee CH , Park CB .

Chem Soc Rev. 2020 Aug 7;49(15):5446-5472. doi: 10.1039/d0cs00107d. Epub 2020 Jul 6.

Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders

Serafín V, Gamella M, Pedrero M, Montero-Calle A, Razzino CA, Yáñez-Sedeño P, Barderas R, Campuzano S, Pingarrón JM.

J Pharm Biomed Anal. 2020 Sep 10;189:113437. doi: 10.1016/j.jpba.2020.113437. Epub 2020 Jun 21.

TREM2 ectodomain and its soluble form in Alzheimer's disease

Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z.

J Neuroinflammation. 2020 Jul 7;17(1):204. doi: 10.1186/s12974-020-01878-2.

Biomarkers in the diagnosis and prognosis of Alzheimer's disease

Davda N, Corkill R.

J Neurol. 2020 Aug;267(8):2475-2477. doi: 10.1007/s00415-020-10037-9.

Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer's disease

Yoo SJ, Son G, Bae J, Kim SY, Yoo YK, Park D, Baek SY, Chang KA, Suh YH, Lee YB, Hwang KS, Kim Y, Moon C.

Sci Rep. 2020 Jul 8;10(1):11234. doi: 10.1038/s41598-020-68148-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias